Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium
Authors:
- Morris A. BlajchmanMBMorris A. Blajchman
- Simone A. GlynnSGSimone A. Glynn
- Cassandra D. JosephsonCJCassandra D. Josephson
- Steve H. KleinmanSKSteve H. Kleinman
- 1 October 2010
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 24 (4) , 259-285
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?: Background, Rationale, and Design of a Clinical Trial (Trial of Platelet Prophylaxis) to Assess the Effectiveness of Prophylactic Platelet TransfusionsTransfusion Medicine Reviews, 2010
- Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageNew England Journal of Medicine, 2010
- Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshopTransfusion, 2009
- The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessmentsTransfusion, 2009
- New Strategies for the Optimal Use of Platelet TransfusionsHematology-American Society Hematology Education Program, 2008
- Transfusion Strategies for Patients in Pediatric Intensive Care UnitsNew England Journal of Medicine, 2007
- Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?British Journal of Haematology, 2005
- Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reductionTransfusion, 2005
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT TrialBlood, 2004
- A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infantsThe Journal of Pediatrics, 1993